Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
AI modeling advances big-data drug discovery; leaves open validation for cardiovascular applications.
Robert F. Furchgott (1984) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: